Leadership Overview
Vanda Pharmaceuticals has 4 executives leading key functions including strategy, financial oversight, marketing, and treasury management.
Committed to advancing medical research through genomics, Vanda Pharmaceuticals delivers innovative therapeutic solutions to improve patient lives across global markets.
Committed to advancing medical research through genomics, Vanda Pharmaceuticals delivers innovative therapeutic solutions to improve patient lives across global markets.
Leadership Roles at Vanda Pharmaceuticals
Mihael Polymeropoulos - President, Chief Executive Officer & Chairman
Mihael Polymeropoulos, the President, Chief Executive Officer & Chairman at Vanda Pharmaceuticals, directs the overarching strategic vision for drug discovery and clinical development. By integrating advanced genetics and genomics into the research pipeline, Polymeropoulos ensures the company maintains a competitive edge in the biopharmaceutical sector. This leadership role involves constant collaboration with the Board to align long-term research goals with commercial viability. Overseeing operations across North America, Europe, and Asia, the President, Chief Executive Officer & Chairman drives the expansion of the therapeutic portfolio. Mihael Polymeropoulos maintains rigorous standards for clinical trial integrity while fostering innovation in drug delivery methods. Through precise management of the research and development lifecycle, the executive secures the company's position as a leader in novel therapeutic approaches. This strategic focus supports the mission of improving patient outcomes through science-driven pharmaceutical advancements.
Paul Jones - Chief Financial Officer
Paul Jones, the Chief Financial Officer at Vanda Pharmaceuticals, manages the fiscal health and capital allocation strategies necessary for sustained biopharmaceutical growth. By overseeing financial reporting and investor relations, Jones ensures transparency and stability for the organization. This role requires constant monitoring of market trends across North America, Europe, and Asia to optimize resource distribution for drug development projects. Paul Jones directs the financial planning processes that support the company's research initiatives and commercial strategies. By analyzing complex economic data, the Chief Financial Officer provides the insights needed for the Board to make informed decisions regarding future investments. This leadership function maintains the financial infrastructure required to support the development of novel therapeutic approaches. Through disciplined fiscal management, the executive protects the company's assets while enabling the pursuit of innovative medical solutions that address critical health conditions.
Kevin Moran - Senior Vice President, Chief Financial Officer and Treasurer
Kevin Moran, the Senior Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, manages the treasury functions and liquidity strategies essential for the company's global operations. By overseeing cash management and risk mitigation, Moran ensures the financial flexibility required to fund long-term drug development cycles. This role involves maintaining strong relationships with financial institutions to support the company's presence in North America, Europe, and Asia. Kevin Moran directs the treasury operations that safeguard the capital necessary for ongoing research and clinical trials. By implementing robust financial controls, the Senior Vice President, Chief Financial Officer and Treasurer provides the stability needed for the organization to pursue innovative therapeutic delivery methods. This leadership function supports the broader financial goals of the company by optimizing the balance sheet and ensuring efficient capital deployment. Through precise treasury management, the executive enables the continued advancement of medical research and the delivery of life-improving pharmaceutical products.
Joakim Wijkstrom - Senior Vice President. Chief Marketing Officer. Executive Leadership Team
Joakim Wijkstrom, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team at Vanda Pharmaceuticals, architects the global commercial strategies for the company's pharmaceutical products. By analyzing market demand and patient needs, Wijkstrom drives the successful launch and positioning of novel therapeutic approaches. This role involves coordinating with cross-functional teams to ensure that clinical trial data effectively informs marketing campaigns across North America, Europe, and Asia. Joakim Wijkstrom oversees the development of brand messaging that highlights the unique benefits of the company's drug portfolio. By optimizing commercial outreach, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team ensures that medical innovations reach the patients who require them most. This leadership position requires constant adaptation to the evolving pharmaceutical landscape to maintain market share. Through strategic engagement with healthcare providers, the executive supports the company's mission of improving lives through advanced medical research.
Explore Leadership Teams in Manufacturing
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership TH
AH
CB
Torrent Pharmaceuticals Ltd is the flagship enterprise of the Torrent Group and stands among the leading pharmaceutical companies in India, with a strong and growing international presence. The company is widely recognized for its leadership across key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals and nutritionals, and cosmo-dermatology, while also maintaining a meaningful footprint in diabetology, pain management, gynaecology, oncology and anti-infective treatments. Built on a foundation of scientific excellence and innovation, Torrent Pharma places research and development at the core of its strategy, supported by advanced infrastructure and a highly skilled scientific workforce dedicated to developing high-quality, affordable medicines for patients worldwide.
Company Leadership SG
AS
SS
SM
Founded in 2005, Headquartered in Tokyo, Daiichi Sankyo is a global pharmaceutical company that develops and provides innovative new and generic medicines, as well as advanced drug discovery and delivery methods, serving patients in over 30 countries.
Company Leadership KM
CS
ST
Founded in 1993 and located in Cambridge, Massachusetts, Takeda Oncology is the oncology specialty business unit of Takeda Pharmaceutical. Takeda Oncology develops and produces oncology therapies for patients around the world.
Company Leadership
RS
CB
TF
Frequently Asked Questions Regarding Vanda Pharmaceuticals Top Executives and Leadership Team
